JNJ

New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
Forbes
New York
opioids
opioid crisis
Purdue Pharma
JNJ
Flag link:
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Indorsia
Actelion
JNJ
insomnia
Flag link:
Novartis touts effectiveness, safety of autoimmune drug copies
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease
Flag link:
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
JNJ
NICE
Tremfya
psoriasis
Flag link:
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
JNJ
Tremfya
psoriasis
Flag link:
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Drug Delivery Business News
JNJ
M&A
LifeScan
blood glucose monitoring
devices
Flag link:
Is There an End in Sight for J&J Divestitures?
Is There an End in Sight for J&J Divestitures?
Medical Devices and Diagnostics Industry
JNJ
M&A
LifeScan
Fortive
devices
Flag link:
J&J gets $2.7 billion offer for sterilization unit from Fortive
J&J gets $2.7 billion offer for sterilization unit from Fortive
Yahoo/Reuters
JNJ
Fortive
M&A
sterilzation
Ethicon
Flag link:
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
JNJ
esketamine
major depression
Flag link:
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
M&A
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Biogen
Takeda
Regeneron
Alexion
Flag link:
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
clinical trials
Roche
Genentech
Genmab
JNJ
cancer
Tecentriq
Darzalex
Flag link:
Danish biotech Genmab hit by ending of trial using key cancer drug
Danish biotech Genmab hit by ending of trial using key cancer drug
Reuters
Genmab
JNJ
Janssen
Darzalex
Flag link:
Biopharma M&A: You Ain’t Seen Nothing Yet
Biopharma M&A: You Ain’t Seen Nothing Yet
Barron's
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Regeneron
Alexion
M&A
Flag link:
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Fierce Pharma
JNJ
lawsuit
mesothelioma
Flag link:
Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug
Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug
Medical Marketing and Media
Sun Pharma
JNJ
Yonsa
prostate cancer
Zytiga
Flag link:
Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
Fierce Pharma
JNJ
prostate cancer
Zytiga
Sun Pharma
Yonsa
FDA
Flag link:
J&J, Pfizer, Merck again lead pharma in Fortune 500
J&J, Pfizer, Merck again lead pharma in Fortune 500
Biopharma Dive
Fortune 500
Big Pharma
JNJ
Merck
Pfizer
Flag link:
Congo to begin Ebola vaccinations on Monday
Congo to begin Ebola vaccinations on Monday
Yahoo/Reuters
Congo
ebola virus
vaccines
Merck
JNJ
Flag link:
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Fierce Biotech
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
Flag link:
FDA calls out 39 drug companies for allegedly blocking access to generics
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
Flag link:

Pages